These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4845272)

  • 1. [Effect of large doses of bilignost on certain indicators of liver function].
    Pekerman MIa; Kogan ES
    Sov Med; 1974 Jun; 37(6):150. PubMed ID: 4845272
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disturbance of the bromsulphalein test by previous administration of trijobil].
    Gerhardt W; Tanner E
    Dtsch Gesundheitsw; 1968 Apr; 23(14):625-8. PubMed ID: 5682405
    [No Abstract]   [Full Text] [Related]  

  • 3. [Liver damage in cholelithiasis complicated or not by cholangitis].
    Pokora J; Krawczyk W; Radwan P
    Wiad Lek; 1981 Mar; 34(6):463-9. PubMed ID: 7269591
    [No Abstract]   [Full Text] [Related]  

  • 4. [Usefulness of biochemical liver function tests in patients with cholelithiasis].
    Markert R
    Wiad Lek; 1977 Jul; 30(14):1095-9. PubMed ID: 888430
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the use of the new bile contrast media in normal persons and liver diseases].
    LEUPOLD F; HEUCK F
    Fortschr Geb Rontgenstr; 1955 Oct; 83(4):464-70. PubMed ID: 13285588
    [No Abstract]   [Full Text] [Related]  

  • 6. [Morphological and functional changes in the liver in cholelithiasis].
    Kuznetsov RV
    Sov Med; 1974; 0(4):69-74. PubMed ID: 4838582
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biochemical studies and biopsy examination in the evaluation of liver function in cholelithiasis].
    Markert R
    Pol Tyg Lek; 1977 Jul; 32(27):1041-2. PubMed ID: 896549
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bilimiro (B 11.420) "Bracco"--a new hepatotropic contrast medium for oral cholecystography].
    Lazecki L
    Pol Przegl Radiol Med Nukl; 1973; 37(4):509-11. PubMed ID: 4754004
    [No Abstract]   [Full Text] [Related]  

  • 9. [New information on the biotransport of the x-ray contrast substance, bilignost, in the hepatocyte].
    Sergeev PV; Mashkovtsev IuV; Obratsov NV
    Farmakol Toksikol; 1980; 43(2):180-4. PubMed ID: 7002597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bile-forming function of the liver during artificial contrast study].
    Bol'shev VN
    Farmakol Toksikol; 1980; 43(5):603-6. PubMed ID: 7449992
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cholecystography following cholecystectomy and liver function].
    Tsurumi K; Komatsu K; Miyazaki T
    Shujutsu; 1965 Oct; 19(10):820-8. PubMed ID: 5888130
    [No Abstract]   [Full Text] [Related]  

  • 12. [The pathogenesis of liver functional disorders after cholecystectomy in cholelithiasis].
    Aksenova EM; Vakhrushev IaM
    Ter Arkh; 1999; 71(2):48-52. PubMed ID: 10222554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of the liver in the production of lithogenic bile in man.
    Vlahcevic ZR; Bell C; Swell L
    Gastroenterology; 1970 Jul; 59(1):62-9. PubMed ID: 5426991
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral cholecystographic agents and floating gallstones.
    Gooding GA
    J Clin Ultrasound; 1982 Sep; 10(7):A28-30. PubMed ID: 6815226
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of liver structure and function in patients with uncomplicated gall-stones.
    Naccarato R; Rizzo A; Chiaramonte M; Farini R; Okolicsanyi L; Parenti A; Lise M; D'Amico D; Pedrazzoli S
    Med Chir Dig; 1977; 6(2):65-8. PubMed ID: 875506
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatotropic contrast media].
    Lazecki L
    Pol Przegl Radiol Med Nukl; 1972; 36(1):63-9. PubMed ID: 5012373
    [No Abstract]   [Full Text] [Related]  

  • 17. Disturbances of liver function in biliary tract disease.
    Lindenauer SM; Child CG
    Surg Gynecol Obstet; 1966 Dec; 123(6):1205-11. PubMed ID: 5953950
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of liver function tests in cholelithiasis].
    Anazawa Y; Watabe O; Okamoto H
    Shujutsu; 1969 Aug; 23(8):1044-53. PubMed ID: 5358422
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cholecystocholangiography. (I). On hepatic factors affecting cholecystocholangiography].
    Nanbu K; Kurosawa A; Yamaguchi T; Namihisa T; Shirakabe H
    Rinsho Hoshasen; 1971 Nov; 16(11):922-9. PubMed ID: 5211328
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cholelithiasis. Physiopathologic mechanisms].
    Rautureau J
    Nouv Presse Med; 1972 Jun; 1(23):1553-5. PubMed ID: 5035883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.